Allergy Therapeutics plc (AGY.L)
GBp 7.0
(2.94%)
GBp 7.0
(2.94%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 GBP | N/A |
| 2022 | -0.06 GBP | -198.99% |
| 2021 | -0.02 GBP | -571.43% |
| 2020 | 0.00 GBP | -58.82% |
| 2019 | 0.01 GBP | 104.0% |
| 2018 | 0.01 GBP | 119.69% |
| 2017 | -0.01 GBP | -202.38% |
| 2016 | -0.00 GBP | 81.66% |
| 2015 | -0.02 GBP | -11550.0% |
| 2014 | 0.00 GBP | -87.5% |
| 2013 | 0.00 GBP | 23.08% |
| 2012 | 0.00 GBP | -48.0% |
| 2011 | 0.00 GBP | 129.07% |
| 2010 | -0.01 GBP | -530.0% |
| 2009 | 0.00 GBP | 101.43% |
| 2008 | -0.14 GBP | 44.0% |
| 2007 | -0.25 GBP | 10.71% |
| 2006 | -0.28 GBP | -199.79% |
| 2005 | -0.09 GBP | -145.14% |
| 2004 | -0.04 GBP | -227.0% |
| 2003 | 0.03 GBP | -63.41% |
| 2002 | 0.08 GBP | 210.66% |
| 2001 | -0.07 GBP | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q2 | -0.01 GBP | 0.0% |
| 2022 FY | - GBP | -198.99% |
| 2022 Q4 | -0.02 GBP | 0.0% |
| 2022 Q2 | -0.01 GBP | 0.0% |
| 2021 Q2 | 0.00 GBP | 0.0% |
| 2021 FY | - GBP | -571.43% |
| 2021 Q4 | -0.03 GBP | 0.0% |
| 2020 Q4 | -0.01 GBP | 0.0% |
| 2020 FY | - GBP | -58.82% |
| 2020 Q2 | 0.01 GBP | 0.0% |
| 2019 FY | - GBP | 104.0% |
| 2019 Q4 | -0.01 GBP | 0.0% |
| 2019 Q2 | 0.01 GBP | 0.0% |
| 2018 Q2 | 0.02 GBP | 0.0% |
| 2018 Q4 | -0.01 GBP | 0.0% |
| 2018 FY | - GBP | 119.69% |
| 2017 Q2 | 0.01 GBP | 0.0% |
| 2017 FY | - GBP | -202.38% |
| 2017 Q4 | -0.02 GBP | 0.0% |
| 2016 Q2 | 0.01 GBP | 0.0% |
| 2016 FY | - GBP | 81.66% |
| 2016 Q4 | -0.02 GBP | 0.0% |
| 2015 Q4 | -0.02 GBP | 0.0% |
| 2015 Q2 | 0.00 GBP | 0.0% |
| 2015 FY | - GBP | -11550.0% |
| 2014 FY | - GBP | -87.5% |
| 2014 Q2 | 0.02 GBP | 0.0% |
| 2014 Q4 | -0.01 GBP | 0.0% |
| 2013 FY | - GBP | 23.08% |
| 2013 Q4 | -0.01 GBP | 0.0% |
| 2013 Q2 | 0.01 GBP | 0.0% |
| 2012 Q2 | 0.01 GBP | 0.0% |
| 2012 FY | - GBP | -48.0% |
| 2012 Q4 | -0.01 GBP | -3000.0% |
| 2012 Q3 | 0.00 GBP | -97.44% |
| 2011 Q4 | 0.00 GBP | 0.0% |
| 2011 Q3 | 0.00 GBP | 0.0% |
| 2011 FY | - GBP | 129.07% |
| 2011 Q1 | -0.00 GBP | 0.0% |
| 2011 Q2 | 0.00 GBP | 128.57% |
| 2010 Q1 | 0.00 GBP | 0.0% |
| 2010 FY | - GBP | -530.0% |
| 2010 Q4 | -0.00 GBP | 0.0% |
| 2010 Q3 | -0.00 GBP | 0.0% |
| 2010 Q2 | -0.00 GBP | -520.0% |
| 2009 FY | - GBP | 101.43% |
| 2009 Q2 | 0.00 GBP | 101.6% |
| 2009 Q3 | 0.00 GBP | 0.0% |
| 2009 Q4 | 0.00 GBP | 0.0% |
| 2009 Q1 | -0.03 GBP | 0.0% |
| 2008 Q2 | -0.03 GBP | 49.43% |
| 2008 Q1 | -0.06 GBP | 0.0% |
| 2008 Q3 | -0.03 GBP | 0.0% |
| 2008 Q4 | -0.03 GBP | 0.0% |
| 2008 FY | - GBP | 44.0% |
| 2007 Q4 | -0.06 GBP | 0.0% |
| 2007 Q1 | -0.07 GBP | 0.0% |
| 2007 Q2 | -0.06 GBP | 12.69% |
| 2007 Q3 | -0.06 GBP | 0.0% |
| 2007 FY | - GBP | 10.71% |
| 2006 Q1 | -0.02 GBP | 0.0% |
| 2006 Q4 | -0.07 GBP | 0.0% |
| 2006 Q3 | -0.07 GBP | 0.0% |
| 2006 Q2 | -0.07 GBP | -204.29% |
| 2006 FY | - GBP | -199.79% |
| 2005 Q1 | -0.01 GBP | 0.0% |
| 2005 Q2 | -0.02 GBP | -177.38% |
| 2005 Q3 | -0.02 GBP | 0.0% |
| 2005 Q4 | -0.02 GBP | 0.0% |
| 2005 FY | - GBP | -145.14% |
| 2004 Q3 | -0.01 GBP | 0.0% |
| 2004 Q4 | -0.01 GBP | 0.0% |
| 2004 Q1 | 0.01 GBP | 0.0% |
| 2004 Q2 | -0.01 GBP | -235.48% |
| 2004 FY | - GBP | -227.0% |
| 2003 Q4 | 0.01 GBP | 0.0% |
| 2003 Q1 | 0.02 GBP | 0.0% |
| 2003 FY | - GBP | -63.41% |
| 2003 Q2 | 0.01 GBP | -69.9% |
| 2003 Q3 | 0.01 GBP | 0.0% |
| 2002 Q2 | 0.02 GBP | 211.35% |
| 2002 FY | - GBP | 210.66% |
| 2002 Q4 | 0.02 GBP | 0.0% |
| 2002 Q3 | 0.02 GBP | 0.0% |
| 2002 Q1 | -0.02 GBP | 0.0% |
| 2001 Q2 | -0.02 GBP | 0.0% |
| 2001 Q3 | -0.02 GBP | 0.0% |
| 2001 Q4 | -0.02 GBP | 0.0% |
| 2001 FY | - GBP | 0.0% |
| Name | Eps | Eps Difference |
|---|